Why the Next Billion Dollar Longevity Opportunity May Not Be a ProductEntreprenuer

Longevity has no shortage of products, science, capital or consumer interest. The bottleneck is translation: getting promising science validated, understood by clinicians, implemented responsibly and ultimately to patients.

Posted from: this blog via Microsoft Power Automate.

Comments

Popular posts from this blog

Women-Owned Small Business Federal Contract Program (WOSB Program)